Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle 27 pseudogene 3 (CDC27P3) is classified as a pseudogene, meaning that it is a DNA sequence similar to the functional CDC27 gene but does not produce a functional protein due to accumulated mutations[1]. Pseudogenes like CDC27P3 are generally not involved in protein-coding, cell signaling, or disease causation and are considered non-functional remnants of gene evolution[1][3]. Some pseudogenes are studied for potential regulatory roles at the RNA level, but as of current knowledge, CDC27P3 does not have any known biological or therapeutic significance. The functional gene CDC27 (cell division cycle 27), sometimes referred to in literature, is a core component of the anaphase-promoting complex/cyclosome (APC/C), with important roles in cell cycle regulation and cancer, but CDC27P3 is not the same—CDC27P3 is a pseudogene, not a canonical therapeutic target[3][5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 27 pseudogene 3 (CDC27P3).